Early outcomes with utilization of tissue plasminogen activator in COVID-19–associated respiratory distress: A series of five cases

CONCLUSION Administration of thrombolytics was followed by overall improvement in patients' oxygen requirements, and in three cases, prevented progression to mechanical ventilation, without deleterious effects. Clinical trials of thrombolytic therapy would further serve to underscore the efficacy and utility of this therapy. LEVEL OF EVIDENCE Case series of therapeutic effect, Level V.
Source: Journal of Trauma and Acute Care Surgery - Category: Surgery Tags: ORIGINAL ARTICLES Source Type: research